Ladenburg Thalmann has recently reduced BioNano Genomics Inc (BNGO) stock to Neutral rating, as announced on November 15, 2024, according to Finviz. Earlier, on September 10, 2024, BTIG Research had ...

On Tuesday, BioNano Genomics Inc (BNGO) stock saw a decline, ending the day at $0.21 which represents a decrease of $-0.01 or -4.55% from the prior close of $0.22. The stock opened at $0.22 and ...

classes of targeted the The latest update is out from BioNano Genomics ( (BNGO) ). Bionano Genomics has announced a registered direct offering involving the sale of common stock and warrants to ...

SAN DIEGO - Bionano Genomics , Inc. (NASDAQ:BNGO), currently valued at $20.9 million in market capitalization, announced ...

This page features the latest news about the Bionano Genomics stock. Bionano Announces Use ... Results Bionano Genomics , Inc. (Nasdaq: NASDAQ:BNGO) today reported certain unaudited preliminary ...

Revenues for the fourth quarter 2024 are expected to be in the range of $7.9 million to $8.1 million, an estimated decrease ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Bionano Genomics (BNGO) announced publication of a case study from the Shenzhen Maternity and Child Healthcare Hospital, China, demonstrating ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...